scholarly article | Q13442814 |
P356 | DOI | 10.1093/AJE/126.2.310 |
P698 | PubMed publication ID | 3300281 |
P2093 | author name string | Kaslow RA | |
Detels R | |||
Rinaldo CR Jr | |||
Phair JP | |||
Polk BF | |||
Ostrow DG | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | HIV/AIDS | Q12199 |
multicenter clinical trial | Q6934595 | ||
P304 | page(s) | 310-318 | |
P577 | publication date | 1987-08-01 | |
P1433 | published in | American Journal of Epidemiology | Q4744243 |
P1476 | title | The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. | |
P478 | volume | 126 |
Q90233874 | A Comparison of the Liver Fat Score and CT Liver-to-Spleen Ratio as Predictors of Fatty Liver Disease by HIV Serostatus |
Q36401521 | A Cross-sectional Study of the Association Between Chronic Hepatitis C Virus Infection and Subclinical Coronary Atherosclerosis Among Participants in the Multicenter AIDS Cohort Study |
Q24533390 | A High-Density Admixture Map for Disease Gene Discovery in African Americans |
Q47296263 | A Study of the Longitudinal Patterns of Stimulant and Amyl Nitrite Use and Sexual Behavior Pre- and Post-HIV Seroconversion Among MSM. |
Q47096373 | A Web-Based Study of Dog Ownership and Depression Among People Living With HIV. |
Q39776711 | A boosting approach to flexible semiparametric mixed models |
Q33554898 | A candidate gene approach for virally induced cancer with application to HIV-related Kaposi's sarcoma |
Q33721818 | A comparison of ad hoc methods to account for non-cancer AIDS and deaths as competing risks when estimating the effect of HAART on incident cancer AIDS among HIV-infected men. |
Q33812743 | A comparison of two measures of HIV diversity in multi-assay algorithms for HIV incidence estimation |
Q35166235 | A frailty-related phenotype before HAART initiation as an independent risk factor for AIDS or death after HAART among HIV-infected men |
Q34970731 | A longitudinal study of human papillomavirus 16 L1, e6, and e7 seropositivity and oral human papillomavirus 16 infection |
Q36725859 | A model-based approach to estimate the AIDS-free time distribution in homosexual men using longitudinal data |
Q90352300 | A novel density-volume calcium score by non-contrast CT predicts coronary plaque burden on coronary CT angiography: Results from the MACS (Multicenter AIDS cohort study) |
Q50101286 | A prospective study of serum microbial translocation biomarkers and risk of AIDS-related non-Hodgkin lymphoma |
Q72321087 | A screening test for subtle cognitive impairment early in the course of HIV infection |
Q36683821 | A serial risk score approach to disease classification that accounts for accuracy and cost |
Q93204016 | A smoothing-based goodness-of-fit test of covariance for functional data |
Q34357078 | A variable region 3 (V3) mutation determines a global neutralization phenotype and CD4-independent infectivity of a human immunodeficiency virus type 1 envelope associated with a broadly cross-reactive, primary virus-neutralizing antibody response |
Q37246041 | AIDS clinical trials group longitudinal linked randomized trials (ALLRT): rationale, design, and baseline characteristics |
Q44129122 | AIDS-free time and survival of an injecting drug users HIV seroconvertors cohort |
Q37389149 | AIDS-related behavioral research and nursing |
Q30868535 | ANALYSIS OF DEPENDENTLY CENSORED DATA BASED ON QUANTILE REGRESSION. |
Q35217255 | Acceleration of age-associated methylation patterns in HIV-1-infected adults |
Q51986206 | Accounting for leadtime in cohort studies: evaluating when to initiate HIV therapies. |
Q37335481 | Acute HIV-1 seroconversion with an unusual plasma biomarker profile |
Q35587294 | Adiponectin and interleukin-6, but not adipose tissue, are associated with worse neurocognitive function in HIV-infected men |
Q36419116 | Adult HIV care resources, management practices and patient characteristics in the Phase 1 IeDEA Central Africa cohort |
Q29999107 | Adversity and Syndemic Production Among Men Participating in the Multicenter AIDS Cohort Study: A Life-Course Approach |
Q33803909 | Age and racial/ethnic differences in the prevalence of reported symptoms in human immunodeficiency virus-infected persons on antiretroviral therapy |
Q34982616 | Age patterns of Kaposi's sarcoma incidence in a cohort of HIV-infected men |
Q33684558 | Age, comorbidities, and AIDS predict a frailty phenotype in men who have sex with men |
Q50104576 | An Environmental influences on Child Health Outcomes viewpoint of data analysis centers for collaborative study designs |
Q40187684 | An increased rate of fracture occurs a decade earlier in HIV+ compared with HIV- men. |
Q36841135 | Anal cancer screening behaviors and intentions in men who have sex with men. |
Q30438899 | Analysis of Longitudinal Data with Semiparametric Estimation of Covariance Function |
Q37090972 | Analytic strategies to evaluate the association of time-varying exposures to HIV-related outcomes: Alcohol consumption as an example |
Q37091664 | Anatomic Fat Depots and Coronary Plaque Among Human Immunodeficiency Virus-Infected and Uninfected Men in the Multicenter AIDS Cohort Study |
Q34158338 | Anthropometry in the prediction of sleep disordered breathing in HIV-positive and HIV-negative men |
Q71951280 | Anti-HIV Type 1 Cytotoxic T Lymphocyte Effector Activity and Disease Progression in the First 8 Years of HIV Type 1 Infection of Homosexual Men |
Q37204118 | Antiretroviral therapy-induced changes in plasma lipids and the risk of kidney dysfunction in HIV-infected men |
Q36326038 | Antiviral activity of a Rac GEF inhibitor characterized with a sensitive HIV/SIV fusion assay |
Q28261119 | Application of syndemic theory to black men who have sex with men in the Multicenter AIDS Cohort Study |
Q34049044 | Assessing agreement in the timing of treatment initiation determined by repeated measurements of novel versus gold standard technologies with application to the monitoring of CD4 counts in HIV‐infected patients |
Q40167904 | Association Between Depressive Symptom Patterns and Clinical Profiles Among Persons Living with HIV. |
Q38722630 | Association between alcohol consumption trajectories and clinical profiles among women and men living with HIV. |
Q35203345 | Association between free testosterone levels and anal human papillomavirus types 16/18 infections in a cohort of men who have sex with men |
Q34275856 | Association between human immunodeficiency virus infection and stiffness of the common carotid artery |
Q89937856 | Association between self-reported marijuana use and incident diabetes in women and men with and at risk for HIV |
Q34036498 | Association between systemic inflammation and obstructive sleep apnea in men with or at risk for HIV infection |
Q73512946 | Association of DRB1*1501 with disseminated Mycobacterium avium complex infection in North American AIDS patients |
Q38774632 | Association of HIV infection with biomarkers of kidney injury and fibrosis in the Multicenter AIDS Cohort Study |
Q40332270 | Association of Macrophage Inflammation Biomarkers With Progression of Subclinical Carotid Artery Atherosclerosis in HIV-Infected Women and Men. |
Q59353706 | Association of Urinary Biomarkers of Kidney Injury with Estimated GFR Decline in HIV-Infected Individuals following Tenofovir Disoproxil Fumarate Initiation |
Q37166999 | Association of alpha interferon production with natural killer cell lysis of U937 cells infected with human immunodeficiency virus |
Q50053622 | Association of gene polymorphism of SDF1(CXCR12) with susceptibility to HIV-1 infection and AIDS disease progression: A meta-analysis |
Q68603059 | Association of hepatitis B surface antigen and core antibody with acquisition and manifestations of human immunodeficiency virus type 1 (HIV-1) infection |
Q37172571 | Association of human immunodeficiency virus (HIV) p24 antigenemia with decrease in CD4+ lymphocytes and onset of acquired immunodeficiency syndrome during the early phase of HIV infection |
Q40233420 | Association of long-term patterns of depressive symptoms and attention/executive function among older men with and without human immunodeficiency virus |
Q39151429 | Association of midlife smoking status with change in processing speed and mental flexibility among HIV-seropositive and HIV-seronegative older men: the Multicenter AIDS Cohort Study |
Q36923830 | Association of serum cytokines with oral HPV clearance |
Q34085805 | Associations between HIV infection and subclinical coronary atherosclerosis |
Q28552882 | Associations between Tobacco, Alcohol, and Drug Use with Coronary Artery Plaque among HIV-Infected and Uninfected Men in the Multicenter AIDS Cohort Study |
Q37520935 | Associations between antiretroviral use and subclinical coronary atherosclerosis. |
Q92844412 | Associations between lipids and subclinical coronary atherosclerosis |
Q90281902 | Associations of Urine Biomarkers with Kidney Function Decline in HIV-Infected and Uninfected Men |
Q35767171 | Bayesian posterior distributions without Markov chains |
Q41932346 | Bayesian quantile regression-based partially linear mixed-effects joint models for longitudinal data with multiple features |
Q57460885 | Behavioral changes following HIV seroconversion during the historical expansion of HIV treatment in the United States |
Q68188835 | Behavioral, health and psychosocial factors and risk for HIV infection among sexually active homosexual men: the Multicenter AIDS Cohort Study |
Q34108089 | Beyond repeated-measures analysis of variance: advanced statistical methods for the analysis of longitudinal data in anesthesia research |
Q36933327 | Bimodal virological response to antiretroviral therapy for HIV infection: an application using a mixture model with left censoring |
Q40710519 | Brief Report: Cumulative Tenofovir Disoproxil Fumarate Exposure is Associated With Biomarkers of Tubular Injury and Fibrosis in HIV-Infected Men. |
Q37013998 | Brief Report: Highly Active Antiretroviral Therapy Mitigates Liver Disease in HIV Infection |
Q35908640 | Brief Report: Intestinal Microbiota-Produced Trimethylamine-N-Oxide and Its Association With Coronary Stenosis and HIV Serostatus. |
Q48141762 | Brief report: Circulating markers of fibrosis are associated with immune reconstitution status in HIV-infected men. |
Q39788768 | CAUSAL INFERENCE FOR CONTINUOUS-TIME PROCESSES WHEN COVARIATES ARE OBSERVED ONLY AT DISCRETE TIMES. |
Q35800805 | CD4+ T-cell counts and plasma HIV-1 RNA levels beyond 5 years of highly active antiretroviral therapy |
Q33998262 | CD8(+) T-cell gamma interferon production specific for human immunodeficiency virus type 1 (HIV-1) in HIV-1-infected subjects |
Q35562091 | Can we predict the prognosis of HIV infection? How to use the findings of a prospective study |
Q34348772 | Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007 |
Q40666123 | Cardiovascular disease risk scores' relationship to subclinical cardiovascular disease among HIV-infected and HIV-uninfected men. |
Q57795377 | Carotid artery atherosclerosis is associated with mortality in HIV-positive women and men |
Q36661756 | Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008. |
Q77329127 | Cell-associated infectious HIV-1 viral load as a predictor of clinical progression and survival among HIV-1 infected injection drug users and homosexual men |
Q70630011 | Changes in HIV rates and sexual behavior among homosexual men, 1984 to 1988/92 |
Q38973122 | Changes in bone turnover markers with HIV seroconversion and ART initiation |
Q92000635 | Changes in cognition precede changes in HRQoL among HIV+ males: Longitudinal analysis of the multicenter AIDS cohort study |
Q35098059 | Changes in stimulant drug use over time in the MACS: evidence for resilience against stimulant drug use among men who have sex with men |
Q37433073 | Changes in weight and weight distribution across the lifespan among HIV-infected and -uninfected men and women |
Q40907967 | Characterization of T lymphocyte subset alterations by flow cytometry in HIV disease |
Q37116007 | Childhood cancer survivorship research in minority populations: A position paper from the Childhood Cancer Survivor Study. |
Q35175515 | Chronic kidney disease and estimates of kidney function in HIV infection: a cross-sectional study in the multicenter AIDS cohort study |
Q35186832 | Circulating mediators of inflammation and immune activation in AIDS-related non-hodgkin lymphoma. |
Q48764096 | Classifying individuals based on predictors of random effects. Multicenter AIDS Cohort Study |
Q43879459 | Clinical and biological evolution of HIV-1 seroconverters in Abidjan, Côte d'Ivoire, 1997-2000. |
Q28393313 | Cochlear function among HIV-seropositive and HIV-seronegative men and women |
Q36376672 | Cohort Profile: Recruitment cohorts in the neuropsychological substudy of the Multicenter AIDS Cohort Study |
Q34052838 | Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals |
Q42875584 | Comment on "characteristics of B-cell lymphomas in HIV/HCV-coinfected patients during the combined antiretroviral therapy era: an ANRS CO16 LYMPHOVIR cohort study". |
Q36461601 | Comparative risk of liver-related mortality from chronic hepatitis B versus chronic hepatitis C virus infection |
Q37211375 | Comparison of 2 anal cytology protocols to predict high-grade anal intraepithelial neoplasia |
Q37460091 | Comparison of antibodies that mediate HIV type 1 gp120 antibody-dependent cell-mediated cytotoxicity in asymptomatic HIV type 1-positive men and women. |
Q34085800 | Comparison of racial differences in plaque composition and stenosis between HIV-positive and HIV-negative men from the Multicenter AIDS Cohort Study |
Q33686223 | Comparison of two measures of human immunodeficiency virus (HIV) type 1 load in HIV risk groups |
Q36890020 | Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection |
Q34397920 | Considering genetic profiles in functional studies of immune responsiveness to HIV-1. |
Q33825654 | Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection |
Q90434858 | Contrasting Roles of the PD-1 Signaling Pathway in Dendritic Cell-Mediated Induction and Regulation of HIV-1-Specific Effector T Cell Functions |
Q41415881 | Contribution of cohort studies in understanding HIV pathogenesis: introduction of the GRIV cohort and preliminary results |
Q33883560 | Copy-years viremia as a measure of cumulative human immunodeficiency virus viral burden |
Q30570315 | Corrected confidence bands for functional data using principal components |
Q59152686 | Cost-Effectiveness of Earlier Initiation of Antiretroviral Therapy for Uninsured HIV-Infected Adults |
Q35692811 | Cost-effectiveness of Prophylaxis Against Pneumocystis jiroveci Pneumonia in Patients with Crohn's Disease. |
Q36635851 | Cross-reactivity of anti-human immunodeficiency virus type 1 gp41 antibodies with human astrocytes and astrocytoma cell lines. |
Q36622823 | Cumulative exposure to stimulants and immune function outcomes among HIV-positive and HIV-negative men in the Multicenter AIDS Cohort Study |
Q28289603 | Current epidemiology of Pneumocystis pneumonia |
Q33998597 | Cytokine gene expression occurs more rapidly in stimulated peripheral blood mononuclear cells from human immunodeficiency virus-infected persons |
Q37632303 | Cytokine signaling pathway polymorphisms and AIDS-related non-Hodgkin lymphoma risk in the multicenter AIDS cohort study |
Q68277410 | Cytomegalovirus IgG and IgA serum antibodies in a study of HIV infection and HIV related diseases in homosexual Men |
Q37567936 | Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection. |
Q31133099 | Data on serologic inflammatory biomarkers assessed using multiplex assays and host characteristics in the Multicenter AIDS Cohort Study (MACS) |
Q47192174 | Decreased Lung Function and All-cause Mortality in HIV-Infected Individuals |
Q34661384 | Demystifying optimal dynamic treatment regimes |
Q34059416 | Dendritic cells restore CD8+ T cell reactivity to autologous HIV-1 |
Q34255703 | Depression and sexual dysfunction among HIV-positive and HIV-negative men who have sex with men: mediation by use of antidepressants and recreational stimulants |
Q36365758 | Depressive Symptom Trajectories, Aging-Related Stress, and Sexual Minority Stress Among Midlife and Older Gay Men: Linking Past and Present |
Q47631953 | Depressive symptoms over the course of HIV infection before AIDS. |
Q83359228 | Detection of human herpesvirus 8 (HHV-8) in normal prostates |
Q35224991 | Detection of human immunodeficiency virus type 1-specific memory cytotoxic T lymphocytes in freshly donated and frozen-thawed peripheral blood mononuclear cells |
Q36517066 | Detection of p24 antigen with and without immune complex dissociation for longitudinal monitoring of human immunodeficiency virus type 1 infection. |
Q31120341 | Determining Survey Satisficing of Online Longitudinal Survey Data in the Multicenter AIDS Cohort Study: A Group-Based Trajectory Analysis |
Q40751062 | Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations |
Q31034655 | Development of a large urban longitudinal HIV clinical cohort using a web-based platform to merge electronically and manually abstracted data from disparate medical record systems: technical challenges and innovative solutions |
Q88919622 | Differences in Cognitive Function Between Women and Men With HIV |
Q34295961 | Differences in hepatitis C virus prevalence and clearance by mode of acquisition among men who have sex with men. |
Q34357979 | Distribution of chemokine receptor CCR2 and CCR5 genotypes and their relative contribution to human immunodeficiency virus type 1 (HIV-1) seroconversion, early HIV-1 RNA concentration in plasma, and later disease progression |
Q36276472 | Early HLA-B*57-restricted CD8+ T lymphocyte responses predict HIV-1 disease progression |
Q40914453 | Early levels of CD4, neopterin, and beta 2-microglobulin indicate future disease progression. |
Q33585427 | Effect of HAART on incident cancer and noncancer AIDS events among male HIV seroconverters |
Q57033017 | Effect of Testosterone Use on Bone Mineral Density in HIV-infected Men |
Q35878906 | Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation |
Q37321533 | Effect of highly active antiretroviral therapy on incident AIDS using calendar period as an instrumental variable |
Q46473122 | Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma |
Q64239841 | Effect of marijuana smoking on pulmonary disease in HIV-infected and uninfected men: a longitudinal cohort study |
Q38877611 | Effect of pregnancy on HIV disease progression and survival among women in rural Uganda |
Q34813982 | Effect of tuberculosis on the survival of HIV-infected men in a country with low tuberculosis incidence |
Q36974205 | Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T Cells |
Q33961871 | Effects of anticoagulant, processing delay, and assay method (branched DNA versus reverse transcriptase PCR) on measurement of human immunodeficiency virus type 1 RNA levels in plasma |
Q47385673 | Effects of asthma on cell components in peripheral blood among smokers and non‐smokers |
Q54760280 | Effects of covariate measurement error in the initial level and rate of change of an exposure variable. |
Q40248116 | Effects of human TRIM5alpha polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection |
Q36539335 | Effects of syndemics on HIV viral load and medication adherence in the multicentre AIDS cohort study |
Q34609629 | Effects of vitamins, including vitamin A, on HIV/AIDS patients |
Q36811161 | Efficient use of longitudinal CD4 counts and viral load measures in survival analysis |
Q35473503 | Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infection |
Q47099088 | Eliciting community perspectives on research with older adults living with HIV through focus groups |
Q37365672 | Emergence and persistence of CXCR4-tropic HIV-1 in a population of men from the multicenter AIDS cohort study |
Q37119980 | Enhanced shedding of cytomegalovirus in semen of human immunodeficiency virus-seropositive homosexual men |
Q35224061 | Enhancement of natural killer cell activity in human immunodeficiency virus-infected subjects by in vitro treatment with biologic response modifier OK-432. |
Q45710433 | Epitope Escape Mutation and Decay of Human Immunodeficiency Virus Type 1-Specific CTL Responses |
Q36315510 | Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication |
Q31075728 | Estimating biomarker-based HIV incidence using prevalence data in high risk groups with missing outcomes |
Q45306426 | Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures |
Q36764936 | Estimation of HIV incidence using multiple biomarkers |
Q58737294 | Estimation of time since exposure for a prevalent cohort |
Q70658656 | Evaluation of a dual-color flow cytometry immunophenotyping panel in a multicenter quality assurance program |
Q33625500 | Evaluation of adherence and factors affecting adherence to combination antiretroviral therapy among White, Hispanic, and Black men in the MACS Cohort |
Q33638209 | Evaluation of human immunodeficiency virus biomarkers: inferences from interval and clinical cohort studies |
Q41995185 | Evolution of CCR5 use before and during coreceptor switching |
Q34730335 | Expression and Function of the Chemokine, CXCL13, and Its Receptor, CXCR5, in Aids-Associated Non-Hodgkin's Lymphoma |
Q36878917 | Extended IL10 haplotypes and their association with HIV progression to AIDS. |
Q36971255 | Extra-coronary calcification (aortic valve calcification, mitral annular calcification, aortic valve ring calcification and thoracic aortic calcification) in HIV seropositive and seronegative men: Multicenter AIDS Cohort Study. |
Q35091365 | Factors affecting glomerular filtration rate, as measured by iohexol disappearance, in men with or at risk for HIV infection |
Q35053172 | Factors affecting the prevalence of strongly and weakly carcinogenic and lower-risk human papillomaviruses in anal specimens in a cohort of men who have sex with men (MSM). |
Q36831346 | Factors affecting timing of antiretroviral treatment initiation based on monitoring CD4 counts |
Q36102525 | Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay |
Q37016878 | Failure to restore the Vgamma2-Jgamma1.2 repertoire in HIV-infected men receiving highly active antiretroviral therapy (HAART). |
Q38888335 | Fall frequency and associated factors among men and women with or at risk for HIV infection |
Q49434882 | Fast covariance estimation for sparse functional data |
Q37140093 | Fc gamma receptor 3A polymorphism and risk for HIV-associated cryptococcal disease |
Q33500150 | Fidelity of SNP array genotyping using Epstein Barr virus-transformed B-lymphocyte cell lines: implications for genome-wide association studies |
Q43926112 | Flow cytometric analysis of γδ T cells and natural killer cells on HIV-1 infection |
Q37664933 | Fond Memories of John Fahey |
Q38948217 | Frailty and Circulating Markers of Inflammation in HIV+ and HIV- Men in the Multicenter AIDS Cohort Study |
Q40050404 | Frailty and subclinical coronary atherosclerosis: The Multicenter AIDS Cohort Study (MACS). |
Q30891062 | Functional data analysis in longitudinal settings using smoothing splines |
Q36893578 | Gaussian models for degradation processes-Part I: Methods for the analysis of biomarker data |
Q46470229 | Gender and long-term metabolic toxicities from antiretroviral therapy in HIV-1 infected persons. |
Q35634901 | Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistence |
Q35845894 | Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. |
Q34658462 | Genetic variation in the CCL18-CCL3-CCL4 chemokine gene cluster influences HIV Type 1 transmission and AIDS disease progression |
Q39406709 | Glomerular filtration rate and proteinuria associations with coronary artery calcium among HIV-infected and HIV-uninfected men in the Multicenter AIDS Cohort Study |
Q93365614 | GlycA, a novel inflammatory marker, is associated with subclinical coronary disease |
Q36842181 | HAART-associated dyslipidemia varies by biogeographical ancestry in the multicenter AIDS cohort study |
Q31088930 | HIV DYNAMICS AND NATURAL HISTORY STUDIES: JOINT MODELING WITH DOUBLY INTERVAL-CENSORED EVENT TIME AND INFREQUENT LONGITUDINAL DATA. |
Q36167498 | HIV Infection Is Associated With Progression of Subclinical Carotid Atherosclerosis |
Q36242596 | HIV Infection Is Associated with Increased Fatty Infiltration of the Thigh Muscle with Aging Independent of Fat Distribution |
Q37055020 | HIV Infection and Carotid Artery Intima-media Thickness: Pooled Analyses Across 5 Cohorts of the NHLBI HIV-CVD Collaborative |
Q40707587 | HIV Infection, Tenofovir, and Urine α1-Microglobulin: A Cross-sectional Analysis in the Multicenter AIDS Cohort Study |
Q35875428 | HIV and coronary arterial remodeling from the Multicenter AIDS Cohort Study (MACS) |
Q37546766 | HIV diversity as a biomarker for HIV incidence estimation: including a high-resolution melting diversity assay in a multiassay algorithm |
Q36495553 | HIV incidence determination in the United States: a multiassay approach |
Q36199708 | HIV infection is associated with an increased prevalence of coronary noncalcified plaque among participants with a coronary artery calcium score of zero: Multicenter AIDS Cohort Study (MACS) |
Q37354530 | HIV infection is associated with reduced pulmonary diffusing capacity |
Q35766031 | HIV monoinfection is associated with increased aspartate aminotransferase-to-platelet ratio index, a surrogate marker for hepatic fibrosis |
Q37679165 | HIV therapy, metabolic and cardiovascular health are associated with glomerular hyperfiltration among men with and without HIV infection |
Q30397933 | HIV-1 envelope subregion length variation during disease progression |
Q38524329 | HIV-1 gp120: a novel viral B cell superantigen |
Q44933768 | HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). |
Q47399269 | HIV-antibody complexes enhance production of type I interferon by plasmacytoid dendritic cells |
Q27693307 | HIV-associated lung infections and complications in the era of combination antiretroviral therapy |
Q46947584 | HIV-related peripheral neuropathy and glucose dysmetabolism: study of a public dataset |
Q41159273 | Hand preference in homosexual men. |
Q44274014 | Haplotype analysis of the SDF-1 (CXCL12) gene in a longitudinal HIV-1/AIDS cohort study |
Q73317826 | Haplotype diversity in the interleukin-4 gene is not associated with HIV-1 transmission and AIDS progression |
Q57313900 | Health-related quality of life among people with HIV disease: results from the Multicenter AIDS Cohort Study |
Q37646944 | Hearing Loss and Quality of Life (QOL) among Human Immunodeficiency Virus (HIV)-Infected and Uninfected Adults |
Q30416349 | Hearing loss among HIV-seropositive and HIV-seronegative men and women |
Q33819311 | Hepatitis B and long-term HIV outcomes in coinfected HAART recipients |
Q33936159 | Hepatitis C virus infection in a male homosexual cohort: risk factor analysis |
Q36084113 | Herpes simplex virus type 2 (HSV-2) as a coronary atherosclerosis risk factor in HIV-infected men: multicenter AIDS cohort study |
Q33947800 | Heterogeneity of CD4+ and CD8+ T-cell responses to cytomegalovirus in HIV-infected and HIV-uninfected men who have sex with men. |
Q35846166 | High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors |
Q35890788 | High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors. |
Q34406750 | Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort |
Q37438634 | Higher risk of AIDS or death in patients with lower CD4 cell counts after virally suppressive HAART |
Q40201626 | Highly Human Immunodeficiency Virus-Exposed Seronegative Men Have Lower Mucosal Innate Immune Reactivity |
Q68016189 | Homosexual and bisexual men's perceptions of discrimination in health services |
Q33399724 | Host HLA B*allele-associated multi-clade Gag T-cell recognition correlates with slow HIV-1 disease progression in antiretroviral therapy-naïve Ugandans |
Q35787248 | Human genes that limit AIDS. |
Q34237804 | Human herpesvirus 8 induces polyfunctional B lymphocytes that drive Kaposi's sarcoma |
Q34353398 | Human immunodeficiency virus type 1 env evolves toward ancestral states upon transmission to a new host. |
Q33649232 | Human immunodeficiency virus type 1 has an additional coding sequence in the central region of the genome |
Q36201371 | Identification of the transcripts associated with spontaneous HCV clearance in individuals co-infected with HIV and HCV |
Q27028033 | Identifying the appropriate comparison group for HIV-infected individuals |
Q39685744 | Immune-mediated positive selection drives human immunodeficiency virus type 1 molecular variation and predicts disease duration. |
Q88626677 | Impact of glycemic status on longitudinal cognitive performance in men with and without HIV infection |
Q39765183 | Impacts of HIV infection and HAART use on quality of life |
Q40344458 | Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences |
Q35823114 | Improved estimation of the distribution of suppressed plasma HIV-1 RNA in men receiving effective antiretroviral therapy |
Q34495613 | Inaccuracy of haemoglobin A1c among HIV-infected men: effects of CD4 cell count, antiretroviral therapies and haematological parameters |
Q37710115 | Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study |
Q36240585 | Incident Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Men Who Have Sex With Men From Pre-HAART to HAART Periods: A Cohort Study. |
Q36892890 | Incident hepatitis C virus infection in men who have sex with men: a prospective cohort analysis, 1984-2011. |
Q33916829 | Incorrect identification of recent HIV infection in adults in the United States using a limiting-antigen avidity assay |
Q58702865 | Increased risk of depression in non-depressed HIV infected men with sleep disturbance: Prospective findings from the Multicenter AIDS Cohort Study |
Q37497586 | Increases in duration of first highly active antiretroviral therapy over time (1996-2009) and associated factors in the Multicenter AIDS Cohort Study |
Q40637001 | Inflammatory Biomarkers and Mortality Risk Among HIV-Suppressed Men: A Multisite Prospective Cohort Study |
Q37076185 | Inflammatory Markers Associated With Subclinical Coronary Artery Disease: The Multicenter AIDS Cohort Study. |
Q36445470 | Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study |
Q64077947 | Inflammatory biomarkers and subclinical carotid atherosclerosis in HIV-infected and HIV-uninfected men in the Multicenter AIDS Cohort Study |
Q43542210 | Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection |
Q35569290 | Influence of gender on receipt of guideline-based antiretroviral therapy in the era of HAART |
Q41828783 | Influence of random genetic drift on human immunodeficiency virus type 1 env evolution during chronic infection |
Q35843765 | Injection drug use and patterns of highly active antiretroviral therapy use: an analysis of ALIVE, WIHS, and MACS cohorts |
Q26786887 | Innovations in health and demographic surveillance systems to establish the causal impacts of HIV policies |
Q37115634 | Interaction between RANTES promoter variant and CCR5Delta32 favors recovery from hepatitis B. |
Q77977590 | Interaction of Herpes Viruses with HIV: Can Antiherpes Drugs Prolong Survival Among AIDS Patients? |
Q36399997 | Internalized gay ageism, mattering, and depressive symptoms among midlife and older gay-identified men |
Q34263748 | Investigation of pre-diagnostic virological markers for progressive multifocal leukoencephalopathy in human immunodeficiency virus-infected patients |
Q38768887 | Invited Commentary: A Landmark Study Launched in a Public Health Maelstrom. |
Q37003522 | It gets better: resolution of internalized homophobia over time and associations with positive health outcomes among MSM. |
Q30543136 | Joint effects of alcohol consumption and high-risk sexual behavior on HIV seroconversion among men who have sex with men |
Q30832318 | Joint modeling of longitudinal and survival data with missing and left-censored time-varying covariates |
Q34778288 | Kaposi sarcoma-associated herpesvirus serum DNA and antibodies not associated with subsequent non-Hodgkin lymphoma risk |
Q36024460 | Kidney Dysfunction and Markers of Inflammation in the Multicenter AIDS Cohort Study |
Q60921320 | Kidney disease risk factors associate with urine biomarkers concentrations in HIV-positive persons; a cross-sectional study |
Q36617741 | Labor force participation and health-related quality of life in HIV-positive men who have sex with men: the Multicenter AIDS Cohort Study |
Q30367604 | Lack of evidence for changing virulence of HIV-1 in North America. |
Q24596652 | Large-scale candidate gene analysis of spontaneous clearance of hepatitis C virus |
Q33818582 | Late-emerging strains of HIV induce T-cell homeostasis failure by promoting bystander cell death and immune exhaustion in naïve CD4 and all CD8 T-cells |
Q35371056 | Level of adherence and HIV RNA suppression in the current era of highly active antiretroviral therapy (HAART) |
Q33999560 | Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: quality control procedures |
Q35017912 | Limitation of inverse probability-of-censoring weights in estimating survival in the presence of strong selection bias |
Q33989047 | Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study |
Q36462022 | Long-term impact of HIV wasting on physical function |
Q54251927 | Long-term kidney function, proteinuria, and associated risks among HIV-infected and uninfected men. |
Q37392589 | Long-term predictive value of the Framingham Risk Score for Stroke in HIV-positive vs HIV-negative men. |
Q27477781 | Long-term serologic follow-up of hepatitis C virus-seropositive homosexual men |
Q36462095 | Longitudinal Changes Over 10 Years in Free Testosterone Among HIV-Infected and HIV-Uninfected Men |
Q58184281 | Longitudinal Trends in the Use of Illicit Drugs and Alcohol in the Multicenter AIDS Cohort Study |
Q36628405 | Longitudinal assessment of de novo T cell production in relation to HIV-associated T cell homeostasis failure |
Q34748660 | Longitudinal psychomotor speed performance in human immunodeficiency virus-seropositive individuals: impact of age and serostatus |
Q37057982 | Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men. |
Q36421999 | Low free testosterone in HIV-infected men is not associated with subclinical cardiovascular disease |
Q36949471 | Low physical function as a risk factor for incident diabetes mellitus and insulin resistance |
Q49360980 | Low thigh muscle mass is associated with coronary artery stenosis among HIV-infected and HIV-uninfected men: The Multicenter AIDS Cohort Study (MACS). |
Q35692221 | Low-Density Lipoprotein Cholesterol Levels and Statin Treatment by HIV Status Among Multicenter AIDS Cohort Study Men. |
Q37667660 | Lower adiponectin is associated with subclinical cardiovascular disease among HIV-infected men. |
Q35688460 | Lung cancer incidence and survival among HIV-infected and uninfected women and men. |
Q42983945 | MICA and recovery from hepatitis C virus and hepatitis B virus infections |
Q33944101 | MaGiK method of T-Cell receptor repertoire analysis. |
Q33883928 | Mannose binding lectin genotypes influence recovery from hepatitis B virus infection |
Q35767162 | Marginal structural models for case-cohort study designs to estimate the association of antiretroviral therapy initiation with incident AIDS or death. |
Q40225120 | Marijuana use impacts midlife cardiovascular events in HIV-infected men. |
Q46725639 | Marker values at the time of an AIDS diagnosis |
Q74597334 | Markers and determinants of progression of HIV-1 infection |
Q41934612 | Metabolic health across the body mass index spectrum in HIV-Infected and HIV-Uninfected Men. |
Q41172186 | Metacognition in HIV-1 seropositive asymptomatic individuals: self-ratings versus objective neuropsychological performance. Multicenter AIDS Cohort Study (MACS). |
Q82869423 | Minimization of genetic distances by the consensus, ancestral, and center-of-tree (COT) sequences for HIV-1 variants within an infected individual and the design of reagents to test immune reactivity |
Q38853942 | Mining for pairs: shared clinic visit dates identify steady HIV-positive partnerships. |
Q31145490 | Mixed hidden Markov quantile regression models for longitudinal data with possibly incomplete sequences. |
Q36550686 | Mixed membership trajectory models of cognitive impairment in the multicenter AIDS cohort study |
Q40118737 | Model assessment in dynamic treatment regimen estimation via double robustness. |
Q73911296 | Models for residual time to AIDS |
Q45958007 | Mortality among participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study. |
Q56915011 | Multiple imputation for competing risks regression with interval-censored data |
Q34085996 | Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDS. |
Q36475300 | Neurologic disorders incidence in HIV+ vs HIV- men: Multicenter AIDS Cohort Study, 1996-2011. |
Q36450742 | Neurological complications in AIDS patients receiving HAART: a 2-year retrospective study |
Q35938577 | Neurological complications in AIDS patients: the 1-year retrospective study in Chiang Mai University, Thailand |
Q35430437 | Neurological complications in late-stage hospitalized patients with HIV disease |
Q54211478 | Neuropsychological phenotypes among men with and without HIV disease in the multicenter AIDS cohort study. |
Q36597909 | Neuropsychological test performance before and after HIV-1 seroconversion: the Multicenter AIDS Cohort Study |
Q45937838 | Non-Hodgkin's B cell lymphoma in persons with acquired immunodeficiency syndrome is associated with increased serum levels of IL10, or the IL10 promoter −592 C/C genotype |
Q94568878 | Noninfectious Comorbidity in the African Cohort Study |
Q46635691 | Nonparametric mixed effects models for unequally sampled noisy curves |
Q33292665 | Normative data for a brief neuropsychological screening battery. Multicenter AIDS Cohort Study |
Q37425787 | Observation plans in longitudinal studies with time-varying treatments. |
Q43759856 | Ocular manifestations of acquired immune deficiency syndrome |
Q36834272 | Online health-searching behavior among HIV-seropositive and HIV-seronegative men who have sex with men in the Baltimore and Washington, DC area |
Q51677743 | Optimal dynamic regimes: presenting a case for predictive inference. |
Q50051756 | Optimal metrics for identifying long term patterns of depression in older HIV-infected and HIV-uninfected men who have sex with men. |
Q39505829 | Oral fluids as an alternative to serum for measurement of markers of immune activation. |
Q36219767 | Osteoprotegerin, but Not Receptor Activator for Nuclear Factor-κB Ligand, is Associated With Subclinical Coronary Atherosclerosis in HIV-Infected Men |
Q38907127 | Parametric functional principal component analysis |
Q93167174 | Partial Normalization of Biomarkers of Inflammation and Immune Activation Among Virally Suppressed Men With HIV Infection and High ART Adherence |
Q30993937 | Partly conditional survival models for longitudinal data |
Q92862224 | Pathways to Recovery: Recovery housing models for men who have sex with men (MSM) |
Q35080053 | Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States |
Q39029428 | Persistence of dual-tropic HIV-1 in an individual homozygous for the CCR5 Delta 32 allele. |
Q58142052 | Pet Ownership and the Reliability of the Companion Animal Bonding Scale Among Participants of the Multicenter Aids Cohort Study |
Q36330073 | Physical Activity and Its Association with Insulin Resistance in Multicenter AIDS Cohort Study Men. |
Q92844406 | Plasma acylcarnitines and progression of carotid artery atherosclerosis in HIV infection |
Q50132706 | Plasma tryptophan-kynurenine metabolites are altered in HIV infection and associated with progression of carotid artery atherosclerosis. |
Q36320562 | Platelet decline as a predictor of brain injury in HIV infection |
Q34764016 | Possession of HLA class II DRB1*1303 associates with reduced viral loads in chronic HIV-1 clade C and B infection |
Q41496836 | Predictive Bayesian inference and dynamic treatment regimes. |
Q35035472 | Predictors of CD4:CD8 ratio normalization and its effect on health outcomes in the era of combination antiretroviral therapy |
Q36555268 | Predictors of the isolated hepatitis B core antibody pattern in HIV-infected and -uninfected men in the multicenter AIDS cohort study |
Q56898222 | Preevaluation of clinical trial data: the case of preemptive cytomegalovirus therapy in patients with human immunodeficiency virus |
Q37399302 | Premature aging of T cells is associated with faster HIV-1 disease progression |
Q40467968 | Prevalence and correlates of marijuana use among HIV-seropositive and seronegative men in the Multicenter AIDS Cohort Study (MACS), 1984-2013. |
Q58752157 | Prevalence and trends of polypharmacy among HIV-positive and -negative men in the Multicenter AIDS Cohort Study from 2004 to 2016 |
Q34295513 | Prevalence of abnormalities in vestibular function and balance among HIV-seropositive and HIV-seronegative women and men |
Q35529950 | Prevalence of chlamydia and gonorrhoea among a population of men who have sex with men |
Q41615487 | Primary HIV infection. Early diagnosis and treatment are critical to outcome |
Q33814693 | Primary virus envelope cross-reactivity of the broadening neutralizing antibody response during early chronic human immunodeficiency virus type 1 infection. |
Q33835126 | Processing and presentation of exogenous HLA class I peptides by dendritic cells from human immunodeficiency virus type 1-infected persons |
Q35280089 | Progression of HIV-infection: markers or determinants |
Q58479192 | Prospective Study of Attitudinal and Relationship Predictors of Sexual Risk in the Multicenter AIDS Cohort Study |
Q40185141 | Prospective accuracy for longitudinal markers |
Q51992650 | Psychiatric disorder in HIV infection. |
Q46220361 | Psychological risk factors for HIV pathogenesis: mediation by the autonomic nervous system |
Q33798752 | Quality of data collection in a large HIV observational clinic database in sub-Saharan Africa: implications for clinical research and audit of care |
Q77323068 | Quantification of cytokine mRNA in peripheral blood mononuclear cells using branched DNA (bDNA) technology |
Q35062931 | Quantifying the decrement in utility from perceived side effects of combination antiretroviral therapies in patients with HIV. |
Q35871314 | Rapid evolution of human immunodeficiency virus strains with increased replicative capacity during the seronegative window of primary infection |
Q37235906 | Reactivation of Epstein-Barr virus during early infection with human immunodeficiency virus |
Q28472689 | Recombination rate and selection strength in HIV intra-patient evolution |
Q33822624 | Recreational amphetamine use and risk of HIV-related non-Hodgkin lymphoma |
Q24650832 | Recreational drug use and T lymphocyte subpopulations in HIV-uninfected and HIV-infected men |
Q34309880 | Recreational drug use and risk of Kaposi's sarcoma in HIV- and HHV-8-coinfected homosexual men. |
Q83276079 | Recruiting minority men who have sex with men for HIV research: results from a 4-city campaign |
Q49109414 | Recruitment for controlled clinical trials: literature summary and annotated bibliography |
Q40394355 | Regularization for generalized additive mixed models by likelihood-based boosting |
Q42667085 | Regulatory T cell expansion and immune activation during untreated HIV type 1 infection are associated with disease progression |
Q39811063 | Relation of impaired lymphocyte proliferative function to other major human immunodeficiency virus type 1-induced immunological changes. |
Q51763954 | Relationship Between T-Cell Responses to CMV, Markers of Inflammation, and Frailty in HIV-uninfected and HIV-infected Men in the Multicenter AIDS Cohort Study. |
Q44690514 | Relationship between IL-2 receptor expression and proliferative responses in lymphocytes from HIV-1 seropositive homosexual men. |
Q37235079 | Relationship between a frailty-related phenotype and progressive deterioration of the immune system in HIV-infected men. |
Q34621738 | Representativeness of an HIV cohort of the sites from which it is recruiting: results from the Ontario HIV Treatment Network (OHTN) cohort study |
Q73217871 | Risk behaviours and HIV infection among men having sexual relations with men: baseline characteristics of participants in the Omega Cohort Study, Montreal, Quebec, Canada |
Q34882577 | Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults |
Q34049896 | Risk factors for fatty liver in the Multicenter AIDS Cohort Study |
Q35758895 | Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults |
Q73710650 | Risk-taking in the Era of Highly Active Antiretroviral Therapy |
Q34240359 | SNP screening of central MHC-identified HLA-DMB as a candidate susceptibility gene for HIV-related Kaposi's sarcoma |
Q36068205 | Screening low-frequency SNPS from genome-wide association study reveals a new risk allele for progression to AIDS |
Q36018359 | Selection of a potential diagnostic biomarker for HIV infection from a random library of non-biological synthetic peptoid oligomers |
Q35224138 | Selective decrease in human immunodeficiency virus type 1 (HIV-1)-induced alpha interferon production by peripheral blood mononuclear cells during HIV-1 infection |
Q90234439 | Self-perception of aging among HIV-positive and HIV-negative participants in the Multicenter AIDS Cohort Study |
Q34601818 | Self-reported body fat change in HIV-infected men is a marker of decline in physical health-related quality of life with aging, independent of co-morbidity |
Q36949710 | Self-reported low physical function is associated with diabetes mellitus and insulin resistance in HIV-positive and HIV-negative men. |
Q47639774 | Sensitivity analyses for unmeasured confounding assuming a marginal structural model for repeated measures |
Q68074396 | Seroepidemiology of HIV infection in two cohorts of intravenous drug users in New York City |
Q35148566 | Serologic responses to pneumocystis proteins in HIV patients with and without Pneumocystis jirovecii pneumonia |
Q90368251 | Serological Assessment of 18 Pathogens and Risk of AIDS-Associated Non-Hodgkin Lymphoma |
Q34673391 | Serological immunity to adenovirus serotype 5 is not associated with risk of HIV infection: a case-control study |
Q44646076 | Serum increases and lymphoid cell surface losses of IL-2 receptor CD25 in HIV infection: Distinctive parameters of HIV-induced change |
Q36988704 | Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin B-cell lymphoma risk |
Q37266368 | Serum lipid profiles among patients initiating ritonavir-boosted atazanavir versus efavirenz-based regimens |
Q33893875 | Serum microRNAs in HIV-infected individuals as pre-diagnosis biomarkers for AIDS-NHL. |
Q30373408 | Seven challenges for model-driven data collection in experimental and observational studies. |
Q90016175 | Sex Hormone-Binding Globulin Levels Are Inversely Associated With Nonalcoholic Fatty Liver Disease in HIV-Infected and -Uninfected Men |
Q35219117 | Sex hormones, insulin resistance, and diabetes mellitus among men with or at risk for HIV infection. |
Q36984533 | Sexual activity and Kaposi's sarcoma among human immunodeficiency virus type 1 and human herpesvirus type 8-coinfected men. |
Q72903119 | Sexual behavior research on a cohort of gay men, 1984-1990: can we predict how men will respond to interventions? |
Q30578419 | Sexual risk trajectories among MSM in the United States: implications for pre-exposure prophylaxis delivery |
Q59353114 | Sexual role and HIV-1 set point viral load among men who have sex with men |
Q36730269 | Short communication: feasibility and acceptability of developing a multisite clinical cohort of transgender people with HIV infection |
Q34362794 | Shrinkage Estimation of Varying Covariate Effects Based On Quantile Regression. |
Q33854860 | Sleep disordered breathing, fatigue, and sleepiness in HIV-infected and -uninfected men |
Q37167321 | Smoking enhances risk for new external genital warts in men. |
Q36735762 | Smoothing grouped bivariate data to obtain the incubation period distribution of AIDS. |
Q39561925 | Someone to count on: social support as an effect modifier of viral load suppression in a prospective cohort study. |
Q34783739 | Specific sex drug combinations contribute to the majority of recent HIV seroconversions among MSM in the MACS. |
Q39539916 | Speech audiometry findings from HIV+ and HIV- adults in the MACS and WIHS longitudinal cohort studies |
Q36141258 | Spontaneous Clearance of the Hepatitis C Virus Among Men Who Have Sex With Men. |
Q24672737 | Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free status |
Q39165832 | Stability of Bisexual Behavior and Extent of Viral Bridging Behavior Among Men Who Have Sex with Men and Women |
Q34513996 | Stimulant use and progression to AIDS or mortality after the initiation of highly active antiretroviral therapy |
Q51756658 | Stress and mental health among midlife and older gay-identified men. |
Q52972224 | Structural accelerated failure time models for survival analysis in studies with time-varying treatments. |
Q37700889 | Structure of tumor necrosis factor-alpha haploblocks in European populations |
Q40116631 | Subclinical herpesvirus shedding among HIV-1-infected men on antiretroviral therapy |
Q39359637 | Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV Suppression |
Q34195439 | Survival analysis in infectious disease research: describing events in time |
Q34673766 | Survival attributable to an exposure |
Q37312306 | Temporal stability of serum concentrations of cytokines and soluble receptors measured across two years in low-risk HIV-seronegative men. |
Q51107767 | Ten-year predicted coronary heart disease risk in HIV-infected men and women. |
Q92109298 | Tenofovir disoproxil fumarate initiation and changes in urinary biomarker concentrations among HIV-infected men and women |
Q57298842 | The Association of Fibroblast Growth Factor-23 (FGF-23) with Incident Frailty in HIV-Infected and -Uninfected Individuals |
Q41722812 | The Association of Inflammatory Markers With Nonalcoholic Fatty Liver Disease Differs by Human Immunodeficiency Virus Serostatus |
Q90604301 | The Changing Science of HIV Epidemiology in the United States |
Q57470672 | The Effects of Hepatitis C Infection and Treatment on All-cause Mortality Among People Living With Human Immunodeficiency Virus |
Q34286261 | The GAy MEn Sex StudieS: Anodyspareunia Among Belgian Gay Men |
Q34674925 | The HIV antibody test: why gay and bisexual men want or do not want to know their results |
Q95289784 | The Role of Microbial Translocation and Immune Activation in AIDS-Associated Non-Hodgkin Lymphoma Pathogenesis: What Have We Learned? |
Q34045522 | The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench |
Q34406059 | The Young Men's Survey: methods for estimating HIV seroprevalence and risk factors among young men who have sex with men |
Q35055162 | The association between APOL1 risk alleles and longitudinal kidney function differs by HIV viral suppression status |
Q38907395 | The association between physical activity and cognition in men with and without HIV infection |
Q37616055 | The association of medication use with clearance or persistence of oral HPV infection |
Q35869875 | The cumulative effects of medication use, drug use, and smoking on erectile dysfunction among men who have sex with men. |
Q33813372 | The dual impact of HIV-1 infection and aging on naïve CD4 T-cells: additive and distinct patterns of impairment |
Q37078006 | The effect of HAART on HIV RNA trajectory among treatment-naïve men and women: a segmental Bernoulli/lognormal random effects model with left censoring |
Q35030011 | The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation |
Q36627938 | The effect of antiretroviral therapy on secondary transmission of HIV among men who have sex with men |
Q58737239 | The effectiveness of interventions on incubation of AIDS as measured by secular increases within a population |
Q31121480 | The generalizability of neurocognitive test/retest data derived from a nonclinical sample for detecting change among two HIV+ cohorts |
Q34648354 | The impact of HAART on the respiratory complications of HIV infection: longitudinal trends in the MACS and WIHS cohorts |
Q36419540 | The impact of impaired kidney function and HIV infection on the risk of anemia. |
Q46028367 | The impact of long-term moderate and heavy alcohol consumption on incident atherosclerosis among persons living with HIV. |
Q41981778 | The impact of viral evolution and frequency of variant epitopes on primary and memory human immunodeficiency virus type 1-specific CD8⁺ T cell responses |
Q36746821 | The interaction between smoking status and highly active antiretroviral therapy (HAART) use on the risk of Kaposi's sarcoma (KS) in a cohort of HIV-infected men. |
Q34462958 | The major histocompatibility complex conserved extended haplotype 8.1 in AIDS-related non-Hodgkin lymphoma |
Q35549287 | The mediating role of pain in substance use and depressive symptoms among Multicenter AIDS Cohort Study (MACS) participants |
Q34229301 | The parametric g-formula to estimate the effect of highly active antiretroviral therapy on incident AIDS or death |
Q52040983 | The progression of untreated HIV-1 infection prior to AIDS |
Q34103197 | The relationship between antibody to R7V and progression of HIV type 1 infection |
Q36364740 | The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study |
Q47421718 | The unseen sample in cohort studies: estimation of its size and effect. Multicenter AIDS Cohort Study |
Q39557004 | Therapy naivete in the era of potent antiretroviral therapy |
Q33880815 | Time scale and adjusted survival curves for marginal structural cox models |
Q35881672 | Time-dependent predictive accuracy in the presence of competing risks |
Q24656950 | Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies |
Q57139468 | To T or not to T: Differences in Testosterone Use and Discontinuation by HIV Serostatus among Men who Have Sex with Men |
Q52868528 | To tell or not to tell: the ethical dilemmas of HIV test notification in epidemiologic research. |
Q31024461 | Tolerance bands for functional data |
Q38858380 | Trajectories of Marijuana Use among HIV-seropositive and HIV-seronegative MSM in the Multicenter AIDS Cohort Study (MACS), 1984-2013. |
Q36599321 | Trends and Predictors of Cigarette Smoking Among HIV Seropositive and Seronegative Men: The Multicenter Aids Cohort Study |
Q47630315 | Two-stage orthogonality based estimation for semiparametric varying-coefficient models and its applications in analyzing AIDS data. |
Q39090045 | Unsafe Sexual Behavior Among Gay/Bisexual Men in the Era of Combination Antiretroviral Therapy (cART). |
Q55086161 | Uptake and predictors of anal cancer screening in men who have sex with men. |
Q33566815 | Using marginal structural measurement-error models to estimate the long-term effect of antiretroviral therapy on incident AIDS or death |
Q39744561 | VARIABLE SELECTION IN LINEAR MIXED EFFECTS MODELS |
Q46037368 | Validity of self-reporting of episodes of external genital warts. |
Q36757861 | Value of a quality assessment program in optimizing cryopreservation of peripheral blood mononuclear cells in a multicenter study |
Q33997498 | Viability and recovery of peripheral blood mononuclear cells cryopreserved for up to 12 years in a multicenter study. |
Q90425471 | Victimization in Early Adolescence, Stress, and Depressive Symptoms Among Aging Sexual Minority Men: Findings from the Multicenter AIDS Cohort Study |
Q58076934 | Viremia copy-years and mortality among combination antiretroviral therapy-initiating HIV-positive individuals: how much viral load history is enough? |
Q34537487 | Virologic and Immunologic Response to Highly Active Antiretroviral Therapy |
Q40407612 | Visceral fat is associated with brain structure independent of human immunodeficiency virus infection status |
Q40517679 | Vitamin D Deficiency and Metabolism in HIV-Infected and HIV-Uninfected Men in the Multicenter AIDS Cohort Study |
Q40102586 | Vitamin D Status and Kidney Function Decline in HIV-Infected Men: A Longitudinal Study in the Multicenter AIDS Cohort Study |
Q52726138 | Vitamin D status and immune function reconstitution in HIV-infected men initiating therapy. |
Q39440269 | Women and AIDS. |
Q35154844 | p21(WAF1/CIP1) RNA expression in highly HIV-1 exposed, uninfected individuals |